These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 8707401)

  • 1. Overexpression and mutations of p53 in metastatic malignant melanomas.
    Hartmann A; Blaszyk H; Cunningham JS; McGovern RM; Schroeder JS; Helander SD; Pittelkow MR; Sommer SS; Kovach JS
    Int J Cancer; 1996 Jul; 67(3):313-7. PubMed ID: 8707401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation and expression of TP53 in malignant melanomas.
    Weiss J; Heine M; Arden KC; Körner B; Pilch H; Herbst RA; Jung EG
    Recent Results Cancer Res; 1995; 139():137-54. PubMed ID: 7597286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 mutations in human cutaneous melanoma correlate with sun exposure but are not always involved in melanomagenesis.
    Zerp SF; van Elsas A; Peltenburg LT; Schrier PI
    Br J Cancer; 1999 Feb; 79(5-6):921-6. PubMed ID: 10070891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 gene mutation and expression in naevi and melanomas.
    Sparrow LE; Soong R; Dawkins HJ; Iacopetta BJ; Heenan PJ
    Melanoma Res; 1995 Apr; 5(2):93-100. PubMed ID: 7620345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of p53 gene mutations in cutaneous melanoma.
    Lübbe J; Reichel M; Burg G; Kleihues P
    J Invest Dermatol; 1994 May; 102(5):819-21. PubMed ID: 8176269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between DNA repair-deficiency and high level of p53 mutations in melanoma of Xeroderma pigmentosum.
    Spatz A; Giglia-Mari G; Benhamou S; Sarasin A
    Cancer Res; 2001 Mar; 61(6):2480-6. PubMed ID: 11289118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the TP53 gene in human malignant melanomas derived from sun-exposed skin and unexposed mucosal membranes.
    Ragnarsson-Olding BK; Karsberg S; Platz A; Ringborg UK
    Melanoma Res; 2002 Oct; 12(5):453-63. PubMed ID: 12394187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical detection of p53 in melanomas with rare p53 gene mutations is associated with mdm-2 overexpression.
    Poremba C; Yandell DW; Metze D; Kamanabrou D; Böcker W; Dockhorn-Dworniczak B
    Oncol Res; 1995; 7(7-8):331-9. PubMed ID: 8747596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinogen-specific mutation pattern in the p53 tumour suppressor gene in UV radiation-induced basal cell carcinoma.
    Weihrauch M; Bader M; Lehnert G; Wittekind C; Tannapfel A; Wrbitzky R
    Int Arch Occup Environ Health; 2002 Apr; 75(4):272-6. PubMed ID: 11981662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultraviolet-induced p53 mutations in atypical fibroxanthoma.
    Dei Tos AP; Maestro R; Doglioni C; Gasparotto D; Boiocchi M; Laurino L; Fletcher CD
    Am J Pathol; 1994 Jul; 145(1):11-7. PubMed ID: 8030743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic implications of p53 overexpression in cutaneous melanoma from sun-exposed and nonexposed sites.
    Essner R; Kuo CT; Wang H; Wen DR; Turner RR; Nguyen T; Hoon DS
    Cancer; 1998 Jan; 82(2):309-16. PubMed ID: 9445187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation and expression of the p53 gene in human malignant melanoma.
    Albino AP; Vidal MJ; McNutt NS; Shea CR; Prieto VG; Nanus DM; Palmer JM; Hayward NK
    Melanoma Res; 1994 Feb; 4(1):35-45. PubMed ID: 8032216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of mutant p53 in melanoma.
    Stretch JR; Gatter KC; Ralfkiaer E; Lane DP; Harris AL
    Cancer Res; 1991 Nov; 51(21):5976-9. PubMed ID: 1933861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 gene mutations in human epithelial skin cancers.
    Molès JP; Moyret C; Guillot B; Jeanteur P; Guilhou JJ; Theillet C; Basset-Sèguin N
    Oncogene; 1993 Mar; 8(3):583-8. PubMed ID: 8437842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of skin cancer risk factors in immunosuppressed renal transplant patients shows high levels of UV-specific tandem CC to TT mutations of the p53 gene.
    Queille S; Luron L; Spatz A; Avril MF; Ribrag V; Duvillard P; Hiesse C; Sarasin A; Armand JP; Daya-Grosjean L
    Carcinogenesis; 2007 Mar; 28(3):724-31. PubMed ID: 17065198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for u.v. induction of CDKN2 mutations in melanoma cell lines.
    Pollock PM; Yu F; Qiu L; Parsons PG; Hayward NK
    Oncogene; 1995 Aug; 11(4):663-8. PubMed ID: 7651729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultraviolet exposure as the main initiator of p53 mutations in basal cell carcinomas from psoralen and ultraviolet A-treated patients with psoriasis.
    Seidl H; Kreimer-Erlacher H; Bäck B; Soyer HP; Höfler G; Kerl H; Wolf P
    J Invest Dermatol; 2001 Aug; 117(2):365-70. PubMed ID: 11511317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinogen-specific mutational pattern in the p53 gene in ultraviolet B radiation-induced squamous cell carcinomas of mouse skin.
    Kress S; Sutter C; Strickland PT; Mukhtar H; Schweizer J; Schwarz M
    Cancer Res; 1992 Nov; 52(22):6400-3. PubMed ID: 1423288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the functional integrity of the p53 tumor-suppressor gene in malignant melanoma.
    Knopf A; Plettenberg C; Pickhard A; Bas M; Reifenberger J; Bier H; Balz V
    Melanoma Res; 2011 Oct; 21(5):380-8. PubMed ID: 21691232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas.
    Reifenberger J; Knobbe CB; Sterzinger AA; Blaschke B; Schulte KW; Ruzicka T; Reifenberger G
    Int J Cancer; 2004 Apr; 109(3):377-84. PubMed ID: 14961576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.